Claims
- 1. A 2-benzimidazolylcarbamic ester of the formula ##STR109## or a salt thereof in which X denotes a sulphur atom, an oxygen atom, an SO group or an SO.sub.2 group,
- Z denotes an alkylene group with 1 to 6 carbon atoms in the main chain, which can optionally be substituted by C.sub.1 to C.sub.4 alkyl,
- R denotes a cycloalkyleneimino, cycloalkenylimino or cycloalkadienyleneimino group which has a total of 4 to 7 ring members and/optionally substituted by one or two C.sub.1 to C.sub.4 alkyl groups, and
- R.sup.3 denotes a C.sub.1 to C.sub.4 alkyl group which is unsubstituted or substituted by C.sub.1 -C.sub.4 alkoxy, halogen, trifluoromethyl, cyano or nitro or a C.sub.2 to C.sub.6 alkenyl group.
- 2. A compound according to claim 1, in which
- X denotes an oxygen or sulphur atom,
- Z denotes a straight-chain or branched alkylene group with 1 to 6 carbon atoms,
- R denotes a cycloalkyleneimine group which has a total of 5 to 7 ring members and optionally substituted by one of two
- C.sub.1 to C.sub.4 alkyl groups and in which
- R.sup.1 denotes a C.sub.1 to C.sub.4 group and
- R.sup.3 denotes a C.sub.1 to C.sub.4 alkyl group.
- 3. A pharmaceutical composition containing as an active ingredient an anthelmintically effective amount of a compound according to claim 1 in admixture with a solid, liquid or liquefied gaseous diluent.
- 4. A pharmaceutical composition containing as an active ingredient an anthelmintically effective amount of a compound according to claim 1 in the form of a sterile or physiologically isotonic aqueous solution.
- 5. A composition according to claim 3 containing from 0.5 to 90% by weight of the said active ingredient.
- 6. A medicament in dosage unit form comprising an anthelmintically effective amount of a compound according to claim 1 and an inert pharmaceutical carrier.
- 7. A medicament of claim 6 in the form of tablets, pills, dragees, capsules, ampules, or suppositories.
- 8. A method of combating helminthiases in warm-blooded animals which comprises administering to the animals an anthelmintically effective amount of an active compound according to claim 1 either alone or in admixture with a diluent or in the form of a medicament.
- 9. A method according to claim 8 in which the active compound is administered in an amount of 1 to 100 mg per kg body weight per day.
- 10. A method according to claim 8 or 9 in which the active compound is administered orally or parenterally.
Priority Claims (1)
Number |
Date |
Country |
Kind |
2845537 |
Oct 1978 |
DEX |
|
Parent Case Info
This is a division of Application Ser. No. 083,883, filed Oct. 11, 1979 now U.S. Pat. No. 4,287,199 issued Sept. 1, 1981.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3935209 |
Beard et al. |
Jan 1976 |
|
3969526 |
Gyurik et al. |
Jul 1976 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
83883 |
Oct 1979 |
|